Investigating the Salience of Clinical Meaningfulness and Clinically Meaningful Outcomes in Metastatic Breast Cancer Care Delivery.

IF 4.7 3区 医学 Q1 ONCOLOGY JCO oncology practice Pub Date : 2024-09-19 DOI:10.1200/OP.24.00228
Stephanie L Graff, Emily C Freeman, Meaghan Roach, Rozanne Wilson, Claire Cagle, Sarah Lunsford, Melissa Culhane Maravic, Ricki Fairley, Mary Gullatte, Jeanne Stemland, Paulina Wochal, Julie Katz, Brianna Hoffner, Julie M Scott, Suepattra G May
{"title":"Investigating the Salience of Clinical Meaningfulness and Clinically Meaningful Outcomes in Metastatic Breast Cancer Care Delivery.","authors":"Stephanie L Graff, Emily C Freeman, Meaghan Roach, Rozanne Wilson, Claire Cagle, Sarah Lunsford, Melissa Culhane Maravic, Ricki Fairley, Mary Gullatte, Jeanne Stemland, Paulina Wochal, Julie Katz, Brianna Hoffner, Julie M Scott, Suepattra G May","doi":"10.1200/OP.24.00228","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>As metastatic breast cancer (mBC) treatment evolves, there is a need to understand how clinical meaningfulness, or a meaningful change in a patient's daily life, and clinically meaningful outcomes inform patient-centered care. Partnering with key stakeholders ensures patient-centered research incorporates the knowledge and expertise of advisors with lived experience. We describe a multistakeholder engagement approach to examine how people living with mBC (PLWmBC), caregivers, and health care providers interpret clinical meaningfulness and clinically meaningful outcomes and their influence on mBC treatment decision making and care.</p><p><strong>Methods: </strong>Qualitative focus groups with PLWmBC, caregivers, and health care providers were conducted and analyzed along three overarching themes: interpretations of clinical meaningfulness and clinically meaningful outcomes; treatment recommendations, preferences, and decisions; and implications for clinical practice. Patient-led and professional organizations served as research partners in study design, implementation, and interpretation of findings.</p><p><strong>Results: </strong>Partnerships were established with four patient-led and three professional organizations representing diverse constituencies throughout the United States. Twenty-two focus groups were conducted with 50 PLWmBC, 24 caregivers, and 41 health care providers (oncologists, n = 11; advanced practice providers, n = 13; oncology nurses, n = 17) between March and June 2023. PLWmBC and caregivers were unfamiliar with the concepts of clinical meaningfulness and clinically meaningful outcomes. Although health care providers were familiar, they did not use the terms when discussing treatment with PLWmBC. Across groups, participants emphasized the importance of meaningful outcomes beyond overall survival, including quality of life and improvement in symptoms and functioning. Participants noted that outcomes considered meaningful are individualized and dynamic.</p><p><strong>Conclusion: </strong>This study offers insight into how partnering with patient advocacy and professional organizations can enhance research quality and aid translation of findings to clinical practice, thereby supporting patient-centered care.</p>","PeriodicalId":14612,"journal":{"name":"JCO oncology practice","volume":" ","pages":"OP2400228"},"PeriodicalIF":4.7000,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JCO oncology practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1200/OP.24.00228","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: As metastatic breast cancer (mBC) treatment evolves, there is a need to understand how clinical meaningfulness, or a meaningful change in a patient's daily life, and clinically meaningful outcomes inform patient-centered care. Partnering with key stakeholders ensures patient-centered research incorporates the knowledge and expertise of advisors with lived experience. We describe a multistakeholder engagement approach to examine how people living with mBC (PLWmBC), caregivers, and health care providers interpret clinical meaningfulness and clinically meaningful outcomes and their influence on mBC treatment decision making and care.

Methods: Qualitative focus groups with PLWmBC, caregivers, and health care providers were conducted and analyzed along three overarching themes: interpretations of clinical meaningfulness and clinically meaningful outcomes; treatment recommendations, preferences, and decisions; and implications for clinical practice. Patient-led and professional organizations served as research partners in study design, implementation, and interpretation of findings.

Results: Partnerships were established with four patient-led and three professional organizations representing diverse constituencies throughout the United States. Twenty-two focus groups were conducted with 50 PLWmBC, 24 caregivers, and 41 health care providers (oncologists, n = 11; advanced practice providers, n = 13; oncology nurses, n = 17) between March and June 2023. PLWmBC and caregivers were unfamiliar with the concepts of clinical meaningfulness and clinically meaningful outcomes. Although health care providers were familiar, they did not use the terms when discussing treatment with PLWmBC. Across groups, participants emphasized the importance of meaningful outcomes beyond overall survival, including quality of life and improvement in symptoms and functioning. Participants noted that outcomes considered meaningful are individualized and dynamic.

Conclusion: This study offers insight into how partnering with patient advocacy and professional organizations can enhance research quality and aid translation of findings to clinical practice, thereby supporting patient-centered care.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
调查转移性乳腺癌治疗过程中的临床意义和临床意义结果的显著性。
目的:随着转移性乳腺癌(mBC)治疗的发展,有必要了解临床意义或患者日常生活中有意义的改变以及有临床意义的结果如何影响以患者为中心的护理。与主要利益相关者合作可确保以患者为中心的研究纳入具有生活经验的顾问的知识和专长。我们介绍了一种多利益相关者参与的方法,以研究 mBC 患者(PLWmBC)、护理人员和医疗服务提供者如何解释临床意义和有临床意义的结果及其对 mBC 治疗决策和护理的影响:与男性乳癌患者、护理人员和医疗服务提供者进行了定性焦点小组讨论,并根据以下三个重要主题进行了分析:对临床意义和有临床意义结果的解释;治疗建议、偏好和决定;以及对临床实践的影响。患者领导的组织和专业组织作为研究伙伴参与了研究设计、实施和结果解释:与代表全美不同人群的四个患者主导组织和三个专业组织建立了合作关系。2023 年 3 月至 6 月期间,与 50 名男性乳癌 PLW、24 名护理人员和 41 名医疗服务提供者(肿瘤专家,11 人;高级医疗服务提供者,13 人;肿瘤护士,17 人)进行了 22 次焦点小组讨论。PLWmBC和护理人员不熟悉临床意义和临床意义结果的概念。虽然医疗服务提供者熟悉这些概念,但他们在与 PLWmBC 讨论治疗时并未使用这些术语。在各个小组中,参与者都强调了有意义结果的重要性,而不仅仅是总体存活率,包括生活质量以及症状和功能的改善。参与者指出,有意义的结果是个性化和动态的:本研究深入探讨了与患者权益倡导组织和专业组织合作如何提高研究质量并帮助将研究结果转化为临床实践,从而支持以患者为中心的护理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.40
自引率
7.50%
发文量
518
期刊最新文献
Clinical Relevance of Intensive Laboratory Monitoring With Standard Venetoclax Ramp-Up for Chronic Lymphocytic Leukemia: A Real-World Experience. Evaluation of the Impact of Monitoring for Tumor Lysis During Venetoclax Ramp-Up in Chronic Lymphocytic Leukemia in Routine Clinical Practice. Management of Stage III Non-Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update Clinical Insights. Pregnancy-Associated Breast Cancer: Key Concepts for Optimizing Diagnosis and Treatment. Did I Mess Up Today?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1